期刊文献+

肿瘤相关巨噬细胞是胃癌重要的促进因素 被引量:3

Tumor Associated Macrophages as Major Promoters of Gastric Cancer
原文传递
导出
摘要 目的探讨巨噬细胞与胃癌发生、发展的关系。方法查阅国内、外相关文献并进行综述。结果胃癌微环境能够诱导巨噬细胞分化,而活化的巨噬细胞,尤其是一类肿瘤相关巨噬细胞又能通过分泌多种活性物质在局部促进肿瘤生长、侵袭和转移。结论巨噬细胞,尤其是肿瘤相关巨噬细胞在胃癌的发生、发展中起到了重要的作用,通过研究巨噬细胞与胃癌相互作用的关系,能够更加深入地了解胃癌的发病过程,并有助于找到新的治疗胃癌的方法。 Objective To explore the association ofmacrophages with carcinogenesis and development of gastric cancer. Method The related literatures at home and abroad were consulted and reviewed. Results The microenvironment of gastric cancer could induce the polarization of macrophages, and then the activated macrophages, especially the tumor associated macrophages, could in turn motivate the growth, invasion, and metastasis of tumor cells by secreting a series of active substances. Conclusions Macrophages, especially the tumor associated macrophages play an important role in the carcinogenesis and development of gastric cancer. Investigating the macrophages and their interaction with gastric cancer may lead to a profound understanding of carcinogenesis of gastric cancer as well as opening up a new prospect for treatment.
出处 《中国普外基础与临床杂志》 CAS 2013年第11期1315-1319,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 巨噬细胞 肿瘤相关巨噬细胞 胃恶性肿瘤 综述 Macrophage Tumor associated macrophages Stomach malignant tumor Review
  • 相关文献

参考文献45

  • 1Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan [J]. Postgrad Med J, 2005, 81(957): 419-424.
  • 2Gao L, Nieters A, Brenner H. Meta-analysis: tumour invasion- related genetic polymorphisms and gastric cancer susceptibility [J]. Aliment Pharmacol Ther, 2008, 28(5): 565-573.
  • 3Sica A, Saccani A, Mantovani A. Tumor-associated macrophages: a molecular perspective[J] Int Immunopharmacol, 2002, 2(8): 1045-1054.
  • 4Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization[J]. Trends Immunol, 2004, 25(12): 677-686.
  • 5Moon ML, McNeil LK, Freund GG. Macrophages make me sick: how macrophage activation states influence sickness behavior[J]. Psychoneuroendocrinology, 2011, 36(10): 1431-1440.
  • 6Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions [J]. Immunity, 2010, 32(5): 593-604.
  • 7Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development [ J ]. J Clin Invest, 2007, 117 (5): 1155-1166.
  • 8Sica A, Schioppa T, Mantovani A, et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy [ J ]. Eur J Cancer, 2006, 42(6): 717-727.
  • 9Solinas G, Schiarea S, Liguori M, et al. Tumor-conditioned macrophages secrete migration-stimulating factor: a new markerfor M2-polarization, influencing tumor cell motility [J] J Imm- unol, 2010, 185(1): 642-652. doi: 10.4049/jimmunol. 1000413.
  • 10Duluc D, Delneste Y, Tan F, et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells [J]. Blood, 2007, 110(13): 4319-4330.

二级参考文献11

  • 1Zhou J,Ding T,Pan W,et al.Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.Int J Cancer,2009,125(7):1640-1648.
  • 2Sasaki A,Tanaka F,Mimori K,et al.Prognostic value of tumor-infiltrating FOXP3 + regulatory T cells in patients with hepatocellular carcinoma.Eur J Surg Oncol,2008,34(2):173-179.
  • 3Haas M,Dimmler A,Hohenberger W,et al.Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia.BMC Gastroenterol,2009,9:65.
  • 4Levings MK,Sangregorio R,Galbiati F,et al.IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.J Immunol,2001,166(9):5530-5539.
  • 5Wang W,Goswami S,Sahai E,et al.Tumor cells caught in the act of invading:their strategy for enhanced cell motility.Trends Cell Biol,2005,15(3):138-145.
  • 6van Dongen M,Savage ND,Jordanova ES,et al.Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors.Int J Cancer,2010,127(4):899-909.
  • 7Ju MJ,Qiu SJ,Gao Q,et al.Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma.Cancer Sci,2009,100(7):1267-1274.
  • 8Ma J,Liu L,Che G,et al.The Ml form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.BMC Cancer,2010,10:112.
  • 9Graves DT,Jiang YL,Williamson MJ,et al.Identification of monocyte chemotactic activity produced by malignant cells.Science,1989,245(4925):1490-1493.
  • 10Savage ND,de Boer T,Walburg KV,et al.Human anti-inflammatory macrophages induce Foxp3 + GITR + CD25 + regulatory T cells,which suppress via membrane-bound TGFbeta-1.J Immunol,2008,181(3):2220-2226.

共引文献7

同被引文献54

  • 1Lauren分类:弥漫型、肠型、混合型和不明型(WHO胃癌分类)第4版.2010:53.
  • 2Rosado JO, Henriques JP, Bonatto D. A systems pharmacology analysis of major chemotherapy combination regimens used in gas- tric cancer treatment: predicting potential new protein targets and drugs. Curr Cancer Drug Targets, 2011,11(7):849-869.
  • 3曾候霖,王心见.胃癌组织TAM、MC和LV计数及其临床病理意义[J].医学临床研究,2007,24(11):1916-1918. 被引量:1
  • 4Hidalgo M. Pancreatic cancer[J].N Engl J Med, 2010, 362 (17):1605-1617.
  • 5Helm O, Held-Feindt J, Grage-Griebenow E, et al. Tumor-asso-ciated macrophages exhibit pro- and anti-inflammatory propertiesby which they impact on pancreatic tumorigenesis[J].Int J Cancer, 2014, 135(4):843-861.
  • 6Hamada S, Masamune A, Shimosegawa T. Inflammation and pancreatic cancer:disease promoter and new therapeutic target[J].J Gastroenterol, 2014, 49(4):605-617.
  • 7Steele CW, Jamieson NB, Evans TR, et al. Exploiting inflamma-tion for therapeutic gain in pancreatic cancer[J].Br J Cancer, 2013, 108(5):997-1003.
  • 8Wang W, Hodkinson P, McLaren F, et al. Histologic assessmentof tumor-associated CD45(+) cell numbers is an independent predictor of prognosis in small cell lung cancer[J].Chest, 2013, 143(1):146-151.
  • 9Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comesof age[J].Nature, 2011, 480(7378):480-489.
  • 10Vanneman M, Dranoff G. Combining immunotherapy and targetedtherapies in cancer treatment[J].Nat Rev Cancer, 2012, 12(4):237-251.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部